Minerva Surgical (NASDAQ:UTRS) & InfuSystem (NYSE:INFU) Head-To-Head Analysis

Minerva Surgical (NASDAQ:UTRS) and InfuSystem (NYSE:INFU) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations and earnings.

Volatility & Risk

Minerva Surgical has a beta of 3.92, indicating that its share price is 292% more volatile than the S&P 500. Comparatively, InfuSystem has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500.

Valuation and Earnings

This table compares Minerva Surgical and InfuSystem”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Minerva Surgical	$51.69 million	0.00	-$34.11 million	N/A	N/A
InfuSystem	$134.86 million	0.86	$870,000.00	$0.10	54.60

InfuSystem has higher revenue and earnings than Minerva Surgical.

Insider & Institutional Ownership

71.1% of InfuSystem shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by insiders. Comparatively, 10.2% of InfuSystem shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Minerva Surgical and InfuSystem, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Minerva Surgical	0	0	0	0	0.00
InfuSystem	0	0	0	2	4.00

InfuSystem has a consensus target price of $13.00, indicating a potential upside of 138.10%. Given InfuSystem’s stronger consensus rating and higher probable upside, analysts clearly believe InfuSystem is more favorable than Minerva Surgical.

Profitability

This table compares Minerva Surgical and InfuSystem’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Minerva Surgical	N/A	N/A	N/A
InfuSystem	1.12%	2.78%	1.41%

Summary

InfuSystem beats Minerva Surgical on 10 of the 11 factors compared between the two stocks.

About Minerva Surgical

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

About InfuSystem

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.